BioStock: Several triggers for Pila Pharma in 2022

There is no doubt that type 2 diabetes has become one of the most common diseases with more than half a billion people affected, according to t International Diabetes Federation. Malmö company Pila Pharma with CEO Dorte X Gram develops a new approach, and, since July 2021, the company’s shares are listed on Nasdaq First North Growth Market. Several milestones have already been reached, and there will be several potential triggers for the stock in 2022.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/01/several-triggers-for-pila-pharma-in-2022/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se